Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1213262-03-3

C17H16BrNO4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1213262-03-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1213262-03-3 Structure

  • Basic information

    1. Product Name: C17H16BrNO4
    2. Synonyms: C17H16BrNO4
    3. CAS NO:1213262-03-3
    4. Molecular Formula:
    5. Molecular Weight: 378.222
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1213262-03-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C17H16BrNO4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C17H16BrNO4(1213262-03-3)
    11. EPA Substance Registry System: C17H16BrNO4(1213262-03-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1213262-03-3(Hazardous Substances Data)

1213262-03-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1213262-03-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,3,2,6 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1213262-03:
(9*1)+(8*2)+(7*1)+(6*3)+(5*2)+(4*6)+(3*2)+(2*0)+(1*3)=93
93 % 10 = 3
So 1213262-03-3 is a valid CAS Registry Number.

1213262-03-3Relevant articles and documents

BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS

-

Page/Page column 52-53, (2010/04/06)

Novel benzo[d]oxazole and/or benzo[d]thiazole compounds, pharmaceutical compositions containing the benzo[d]oxazole and/or benzo[d]thiazole compounds, and methods of their pharmaceutical use are disclosed. In certain embodiments, the benzo[d]oxazole and/o

Benzimidazole- and benzoxazole-based inhibitors of Rho kinase

Sessions, E. Hampton,Yin, Yan,Bannister, Thomas D.,Weiser, Amiee,Griffin, Evelyn,Pocas, Jennifer,Cameron, Michael D.,Ruiz, Claudia,Lin, Li,Schuerer, Stephan C.,Schroeter, Thomas,LoGrasso, Philip,Feng, Yangbo

scheme or table, p. 6390 - 6393 (2009/09/06)

Inhibitors of Rho kinase have been developed based on two distinct scaffolds, benzimidazoles, and benzoxazoles. SAR studies and efforts to optimize the initial lead compounds are described. Novel selective inhibitors of ROCK-II with excellent potency in b

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1213262-03-3